论文部分内容阅读
目的:对肝病患者血清检验指标改变的临床价值进行分析和讨论。方法:选择我院在2015年6月-2016年6月期间所收治的共100例健康志愿者和肝病患者作为研究对象,按照健康和肝病患者进行分组,分别为对照组和观察组,每组共有研究对象50例。对两组研究对象进行血清检查,对比两组研究对象的生化指标。结果:观察组当中血清中的GGT、ALP、ALT、FT3以及FT4含量要明显的高于对照组,两组相比较而言差异具有统计学意义(P<0.05)。同时,两组患者在TBA含量上没有发生明显的差异,不具有统计学意义(P>0.05)。结论:肝病患者在血清的检验指标上是会出现与正常健康人群的明显差异,变化比较大,在进行疾病诊断的过程中可以以此作为确诊的依据,对于临床的诊断效果提升具有重要的价值,十分值得在临床上进行推广和应用。
Objective: To analyze and discuss the clinical value of serum test in patients with liver diseases. Methods: A total of 100 healthy volunteers and liver disease patients who were treated in our hospital from June 2015 to June 2016 were selected as the study subjects, and were divided into two groups according to their health and liver diseases: control group and observation group. Each group A total of 50 subjects. Serum tests were performed on two groups of subjects, and the biochemical indexes of the two groups were compared. Results: The levels of GGT, ALP, ALT, FT3 and FT4 in the serum of the observation group were significantly higher than those of the control group. There was significant difference between the two groups (P <0.05). At the same time, there was no significant difference in TBA between the two groups, which was not statistically significant (P> 0.05). Conclusion: There is a significant difference between serum and liver disease in patients with liver disease and normal healthy population, the changes are relatively large, and can be used as the basis for diagnosis in the process of disease diagnosis, which is of great value in clinical diagnosis , It is worth in the clinical promotion and application.